26 Results

People

  1. Sadelain
    Sadelain
  2. Brentjens
    Brentjens
  3. Kentsis
    Kentsis
  4. Chiosis
    Chiosis
  5. Lesokhin
    Lesokhin
  6. Scheinberg
    Scheinberg
  7. Dobrin
    Dobrin
  8. Eyquem
    Eyquem
  9. Hamieh
    Hamieh
  10. Khalil
    Khalil

Groups

  1. Center for Hematologic Malignancies (26)
  2. Hematologic Malignancies Research (26)
  3. GSK Faculty (21)
  4. Department of Medicine (18)
  5. Hematologic Malignancies, Division of (18)
  6. Molecular Pharmacology and Chemistry Program Faculty (17)
  7. Sloan Kettering Institute Faculty (17)
  8. Sloan Kettering Institute Postdocs (9)
  9. Tow Center for Developmental Oncology (TCDO) (9)
  10. Adult Leukemia (8)
  1. "Hematologic Malignancies Research"
  2. "Biomed Central Ltd"
Formats
  1. Journal Article (17)
  2. Meeting Abstract (7)
  3. Guidelines (2)
Groups
  1. Center for Hematologic Malignancies (26)
  2. Hematologic Malignancies Research (26)
  3. GSK Faculty (21)
  4. Department of Medicine (18)
  5. Hematologic Malignancies, Division of (18)
  6. Molecular Pharmacology and Chemistry Program Faculty (17)

More Groups

People
  1. Michel Sadelain (5)
  2. Alex Kentsis (4)
  3. Renier Brentjens (4)
  4. Alexander Lesokhin (3)
  5. David Scheinberg (3)
  6. Gabriela Chiosis (3)

More People

Years
  1. 2023 (1)
  2. 2022 (1)
  3. 2021 (3)
  4. 2020 (3)
  5. 2019 (1)
  6. 2018 (1)

More Years

Publications
  1. Journal for ImmunoTherapy of Cancer (14)
  2. Journal of Hematology & Oncology (3)
  3. BMC Bioinformatics (1)
  4. BMC Gastroenterology (1)
  5. BMC Genomics (1)
  6. BMC Neuroscience (1)

More Publications

Publishers
  1. Biomed Central Ltd (26)

Results (26)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The landscape of MHC-presented phosphopeptides yields actionable shared tumor antigens for cancer immunotherapy across multiple HLA alleles
    Journal Article

    Molvi, Z.; Klatt, M. G.; Dao, T.; Urraca, J.; Scheinberg, D. A.; O'Reilly, R. J.
    Journal for ImmunoTherapy of Cancer (2023)

    Fulltext@MSK | Save
  • CD19-directed chimeric antigen receptor T cell therapy in Waldenström macroglobulinemia: A preclinical model and initial clinical experience
    Journal Article

    Palomba, M. L.; Qualls, D.; Monette, S.; Sethi, S.; Dogan, A.; Roshal, M.; Senechal, B.; Wang, X.; Rivière, I.; Sadelain, M.; more...
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • High quality neoantigens are immunoedited in long-term pancreatic cancer survivors
    Meeting Abstract

    Sethna, Z.; Luksza, M.; Rojas, L.; Soares, K.; Leung, J.; Lihm, J.; Hoyos, D.; Dobrin, A.; Kappagantula, R.; Makohon-Moore, A.; more...
    Journal for ImmunoTherapy of Cancer (2021)

    Fulltext@MSK | Save
  • HLA-independent T cell receptors effectively target low abundance antigens
    Meeting Abstract

    Mansilla-Soto, J.; Eyquem, J.; Haubner, S.; Hamieh, M.; Feucht, J.; Paillon, N.; Zucchetti, A.; Li, Z.; Sjöstrand, M.; Lindenbergh, P.; more...
    Journal for ImmunoTherapy of Cancer (2021)

    Fulltext@MSK | Save
  • First-in-human phase I/Ib open-label dose-escalation study of GWN323 (anti-GITR) as a single agent and in combination with spartalizumab (anti-PD-1) in patients with advanced solid tumors and lymphomas
    Journal Article

    Piha-Paul, S. A.; Geva, R.; Tan, T. J.; Lim, D. W. T.; Hierro, C.; Doi, T.; Rahma, O.; Lesokhin, A.; Luke, J. J.; Otero, J.; more...
    Journal for ImmunoTherapy of Cancer (2021)

    Fulltext@MSK | Save
  • Genomics of multiple myeloma influences the expression of CAR T-cell targets
    Meeting Abstract

    Yu, C.; Walker, B.; Roodman, G. D.; Huang, K.; Sadelain, M.; Perna, F.
    Journal for ImmunoTherapy of Cancer (2020)

    Fulltext@MSK | Save
  • The Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of acute leukemia
    Guidelines

    Boyiadzis, M. M.; Aksentijevich, I.; Arber, D. A.; Barrett, J.; Brentjens, R. J.; Brufsky, J.; Cortes, J.; De Lima, M.; Forman, S. J.; Fuchs, E. J.; more...
    Journal for ImmunoTherapy of Cancer (2020)

    Fulltext@MSK | Save
  • The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of multiple myeloma
    Guidelines

    Shah, N.; Aiello, J.; Avigan, D. E.; Berdeja, J. G.; Borrello, I. M.; Chari, A.; Cohen, A. D.; Ganapathi, K.; Gray, L.; Green, D.; more...
    Journal for ImmunoTherapy of Cancer (2020)

    Fulltext@MSK | Save
  • T cell receptor gene therapy for a public neoantigen derived from mutated PIK3CA, a dominant driver oncogene in breast and endometrial cancers
    Meeting Abstract

    Ma, J.; Klatt, M.; Dundar, F.; Zumbo, P.; Femia, M.; Betel, D.; Scheinberg, D.; Baker, B.; Klebanoff, C.; Chandran, S.
    Journal for ImmunoTherapy of Cancer (2019)

    Fulltext@MSK | Save
  • Chimeric antigen receptor (CAR) T therapies for the treatment of hematologic malignancies: Clinical perspective and significance
    Journal Article

    Boyiadzis, M. M.; Dhodapkar, M. V.; Brentjens, R. J.; Kochenderfer, J. N.; Neelapu, S. S.; Maus, M. V.; Porter, D. L.; Maloney, D. G.; Grupp, S. A.; Mackall, C. L.; more...
    Journal for ImmunoTherapy of Cancer (2018)

    Fulltext@MSK | Save